Filing Details

Accession Number:
0001593968-24-000563
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-08 17:30:37
Reporting Period:
2024-04-04
Accepted Time:
2024-04-08 17:30:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1824893 Surrozen Inc. SRZN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325818 O Charles Williams C/O Surrozen, Inc.
171 Oyster Point Blvd., Suite 400
South San Francisco CA 94080
Cfo And Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-04 1,474 $0.00 1,474 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Common Stock Warrant (right to buy) Acquisiton 2024-04-04 1,474 $0.00 1,474 $16.96
Common Stock Series B Common Stock Warrant (right to buy) Acquisiton 2024-04-04 1,603 $0.00 1,603 $15.71
Common Stock Series C Common Stock Warrant (right to buy) Acquisiton 2024-04-04 5,712 $0.00 5,712 $16.00
Common Stock Series D Common Stock Warrant (right to buy) Acquisiton 2024-04-04 5,712 $0.00 5,712 $16.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,474 2024-04-04 2029-04-04 No 4 P Direct
1,603 2024-04-04 No 4 P Direct
5,712 No 4 P Direct
5,712 No 4 P Direct
Footnotes
  1. On April 4, 2024, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of April 1, 2024, by and among the Issuer and certain institutional investors and members of management, at a purchase price of $16.96 per share, which amount includes $1.25 for the accompanying common stock warrants.
  2. The warrant expires on the fifth trading day following the occurrence of the Series B Milestone Event (as defined in the Series B Common Stock Warrant). In the event the Series B Milestone Event has not occurred prior to the fifth anniversary of the issuance date of the warrant, the warrant will automatically terminate on such anniversary date.
  3. The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series C Milestone Event (as defined in the Series C Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series C Common Stock Warrant).
  4. The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series D Milestone Event (as defined in the Series D Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series D Common Stock Warrant).